Insights

Gathering insights about Vivy…

Similar companies to Vivy

Vivy Tech Stack

Vivy uses 8 technology products and services including Google Analytics, jQuery CDN, Cloudflare, and more. Explore Vivy's tech stack below.

Google Analytics
Analytics
jQuery CDN
Content Delivery Network
Cloudflare
Content Management System
Open Graph
Miscellaneous
Webflow
Page Builders
Android
Programming Languages
JavaScript
Programming Languages
Nginx
Web Servers

Media & News

Invivyd, Inc. (IVVD) Q3 2024 Earnings Call Transcript
Start Time: 08:30 January 1, 0000 9:18 AM ET Invivyd, Inc. (NASDAQ:IVVD ) Q3 2024 Earnings Conference Call November 14, 2024, 08:30 AM ET Company Participants Marc Elia - Chairperson, Board of Directors and Executive Committee Tim Lee - COO Bill Duke - CFO Robert Allen - CSO Mark Wingertzahn - SVP of Clinical Development and Medical Affairs Katie Falzone - VP, Corporate Controller Conference Call Participants Maxwell Skor - Morgan Stanley Michael Yee - Jefferies Jason Kolbert - D. Boral Capital Luis Santos - H.C.
Nov 14, 2024 | seekingalpha.com
Invivyd, Inc. (IVVD) Reports Q3 Loss, Misses Revenue Estimates
Invivyd, Inc. (IVVD) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.36 per share a year ago.
Nov 14, 2024 | www.zacks.com
Invivyd Reports Third Quarter 2024 Financial Results and Recent Business Highlights
WALTHAM, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced financial results for the quarter ended September 30, 2024, and recent business highlights.
Nov 14, 2024 | www.globenewswire.com
Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA™ (pemivibart) Emergency Use Authorization; Comments on Adjacent Third-Party Letter to the Editor
WALTHAM, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announces that The New England Journal of Medicine (NEJM) has published a peer-reviewed Letter to the Editor describing the PEMGARDA™ (pemivibart) immunobridging emergency use authorization (EUA) pathway, as well as an updated correlate of protection (CoP) curve for prevention of symptomatic COVID-19 via recombinant monoclonal antibodies (mAbs) such as pemivibart.
Nov 14, 2024 | www.globenewswire.com
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedRxiv and BioRxiv, Respectively
WALTHAM, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that a manuscript preprint conveying data from the CANOPY Phase 3 clinical trial of pemivibart, a half-life extended investigational monoclonal antibody (mAb) for the pre-exposure prophylaxis (PrEP) of COVID-19, including long-term protection shown versus recent JN.1 sublineages at low residual titers, was uploaded to MedRxiv, and a preprint describing a novel approach for predicting mAb activity was uploaded to BioRxiv.
Nov 12, 2024 | www.globenewswire.com
Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference
WALTHAM, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that management will participate in a fireside chat and 1x1 investor meetings at the Guggenheim Securities Healthcare Innovation Conference taking place November 11-13, 2024.
Nov 06, 2024 | www.globenewswire.com
Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024
WALTHAM, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will host a conference call on Thursday, November 14, 2024, at 8:30 a.m. ET to discuss its financial results for the third quarter ended September 30, 2024, and provide recent business highlights. Invivyd reported preliminary third quarter 2024 results via press release on October 29, 2024.
Nov 06, 2024 | www.globenewswire.com

Vivy's Email Address Formats

Vivy uses at least 1 format(s):

Vivy Email Formats	Example	Percentage
First@vivy.com	John@vivy.com	37%
First.Last@vivy.com	John.Doe@vivy.com	19%
Last@vivy.com	Doe@vivy.com	7%
First@vivy.com	John@vivy.com	37%

Frequently Asked Questions

Where is Vivy's headquarters located?

Vivy's main headquarters is located at Schützenstrasse 18 Berlin, Berlin 10117 DE. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Vivy's stock symbol?

Vivy is a publicly traded company; the company's stock symbol is IVVD.

What is Vivy's official website and social media links?

Vivy's official website is vivy.com and has social profiles on LinkedIn.

How much revenue does Vivy generate?

As of August 2024, Vivy's annual revenue reached $15M.

What is Vivy's NAICS code?

Vivy's NAICS code is 71394 - Fitness and Recreational Sports Centers.

How many employees does Vivy have currently?

As of August 2024, Vivy has approximately 51 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: E. G.Chief Executive Officer (ceo): R. K.Chief Technology Officer: A. S. R.. Explore Vivy's employee directory with LeadIQ.

What industry does Vivy belong to?

Vivy operates in the Wellness and Fitness Services industry.

What technology does Vivy use?

Vivy's tech stack includes Google AnalyticsjQuery CDNCloudflareOpen GraphWebflowAndroidJavaScriptNginx.

What is Vivy's email format?

Vivy's email format typically follows the pattern of . Find more Vivy email formats with LeadIQ.

When was Vivy founded?

Vivy was founded in 2017.

Vivy

Wellness and Fitness ServicesBerlin, Germany51-200 Employees

Vivys Ziel ist es, die führende digitale Gesundheitsplattform für personalisiertes Gesundheitsmanagement zu entwickeln. Wir verbinden Menschen mit den Dienstleistungen, die ihnen dabei helfen, ihre Gesundheit in die Hand zu nehmen und zu verbessern. Vivy ist ein Berliner Startup. Mit Unterstützung der Allianz (der weltweit größten Versicherung), wollen wir die Zukunft des Gesundheitswesens gestalten.
Unser internationales Team im Herzen Berlins ist immer auf der Suche nach ambitionierten und talentierten Mitarbeitern.
Lust mit Vivy die Zukunft digitaler Gesundheit mitzugestalten?